arrow
L

Lawrence Davies

cancer research uk
H指数:21
被引数:1,196

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The paradox-breaking panRAF plus SRC family kinase inhibitor, CCT3833, is effective in mutant KRAS-driven cancers

打破悖论的panRAF加SRC家族激酶抑制剂CCT3833对突变KRAS驱动的癌症有效

2021-02-0114
OAAI
Anti-metastatic Inhibitors of Lysyl Oxidase (LOX): Design and Structure-Activity Relationships
2019-05-0949
OAAI
Novel panRAF inhibitors active in melanomas that are resistant to BRAF-selective, or BRAF-selective/MEK inhibitor combinations
2014-10-010
PRE
Novel tricyclic pyrazole BRAF inhibitors with imidazole or furan central scaffolds
2010-09-0132
OAAI
Development of Novel, Highly Potent Inhibitors of V-RAF Murine Sarcoma Viral Oncogene Homologue B1 (BRAF): Increasing Cellular Potency through Optimization of a Distal Heteroaromatic Group
2010-04-0835
PRE
Pyridoimidazolones as Novel Potent Inhibitors of v-Raf Murine Sarcoma Viral Oncogene Homologue B1 (BRAF) (vol 52, pg 2255, 2009)
2009-08-270
PREAI
Pyridoimidazolones as Novel Potent Inhibitors of v-Raf Murine Sarcoma Viral Oncogene Homologue B1 (BRAF)
2009-03-2647
PREAI